Archive

Neovasc Announces Publication of Safety and Efficacy Results from REDUCE Study in International Journal of Cardiology

NASDAQ, TSX: NVCN VANCOUVER, Aug. 6, 2018 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced publication of the manuscript, "Safety and efficacy of the Reducer: A multicenter clinical registry -...

Read More

Neovasc to Present at the 38th Annual Canaccord Genuity Growth Conference

NASDAQ, TSX: NVCN VANCOUVER, Aug. 6, 2018 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced that Fred Colen, President and Chief Executive Officer of Neovasc, is scheduled to present...

Read More